Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

Maybe you’ve put in hundreds of hours into Arc Raiders since the immensely popular extraction shooter launched at the end of October, but I'm almost certain you haven't played the game's rarest map ...

What’s new in the biotech world? In this listicle, we highlight recent product launches, partnerships and company events ranging in topic from efficient nucleic acid purification and PCR for beverage ...

Advances in artificial intelligence-assisted protein engineering are enabling breakthroughs in protein design, but they also introduce biosecurity challenges related to potential production of harmful ...

Background: New clades and lineages emerged with the globally prevalent of Mpox virus (MPXV), accompanied by changing clinical symptoms, pathogenesis and transmission dynamics in associated with ...

CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...

Beckman Coulter Life Sciences, a Danaher company and global leader in laboratory automation and innovation, is redefining nucleic acid quantification through a strategic collaboration with ...

German CDMO BioSpring is building a new production facility that it hopes will become one of the world's biggest manufacturing sites for DNA- and RNA-based active pharmaceutical ingredients (API). The ...

VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a new commercial partnership and co-marketing agreement with ID Solutions, a French provider of ...